Sepsis and septic shock

被引:2209
作者
Cecconi, Maurizio [1 ]
Evans, Laura [2 ]
Levy, Mitchell [3 ]
Rhodes, Andrew [4 ]
机构
[1] Humanitas Univ, Ist Clin Humanitas, IRCCS, Dept Anaesthesia & Intens Care, I-20089 Milan, Italy
[2] NYU, Bellevue Hosp Ctr, Sch Med, New York, NY 10016 USA
[3] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Providence, RI 02903 USA
[4] St Georges Univ Hosp Fdn Trust, Dept Intens Care Med, London, England
关键词
INTERNATIONAL CONSENSUS DEFINITIONS; POLYMYXIN-B HEMOPERFUSION; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE UNITS; INFLAMMATORY RESPONSE SYNDROME; GOAL-DIRECTED RESUSCITATION; RANDOMIZED CONTROLLED-TRIAL; ORGAN FAILURE ASSESSMENT; SURVIVING SEPSIS; ANTIMICROBIAL THERAPY;
D O I
10.1016/S0140-6736(18)30696-2
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Sepsis is a common condition that is associated with unacceptably high mortality and, for many of those who survive, long-term morbidity. Increased awareness of the condition resulting from ongoing campaigns and the evidence arising from research in the past 10 years have increased understanding of this problem among clinicians and lay people, and have led to improved outcomes. The World Health Assembly and WHO made sepsis a global health priority in 2017 and have adopted a resolution to improve the prevention, diagnosis, and management of sepsis. In 2016, a new definition of sepsis (Sepsis-3) was developed. Sepsis is now defined as infection with organ dysfunction. This definition codifies organ dysfunction using the Sequential Organ Failure Assessment score. Ongoing research aims to improve definition of patient populations to allow for individualised management strategies matched to a patient's molecular and biochemical profile. The search continues for improved diagnostic techniques that can facilitate this aim, and for a pharmacological agent that can improve outcomes by modifying the disease process. While waiting for this goal to be achieved, improved basic care driven by education and quality-improvement programmes offers the best hope of increasing favourable outcomes.
引用
收藏
页码:75 / 87
页数:13
相关论文
共 148 条
[1]
Critical Care 1 Critical care and the global burden of critical illness in adults [J].
Adhikari, Neill K. J. ;
Fowler, Robert A. ;
Bhagwanjee, Satish ;
Rubenfeld, Gordon D. .
LANCET, 2010, 376 (9749) :1339-1346
[2]
Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease [J].
Amaya-Villar, R ;
Garnacho-Montero, J ;
García-Garmendía, J ;
Madrazo-Osuna, J ;
Garnacho-Montero, MC ;
Luque, R ;
Ortiz-Leyba, C .
INTENSIVE CARE MEDICINE, 2005, 31 (01) :157-161
[3]
Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension A Randomized Clinical Trial [J].
Andrews, Ben ;
Semler, Matthew W. ;
Muchemwa, Levy ;
Kelly, Paul ;
Lakhi, Shabir ;
Heimburger, Douglas C. ;
Mabula, Chileshe ;
Bwalya, Mwango ;
Bernard, Gordon R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (13) :1233-1240
[4]
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[5]
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock [J].
Annane, D. ;
Renault, A. ;
Brun-Buisson, C. ;
Megarbane, B. ;
Quenot, J. -P. ;
Siami, S. ;
Cariou, A. ;
Forceville, X. ;
Schwebel, C. ;
Martin, C. ;
Timsit, J. -F. ;
Misset, B. ;
Benali, M. Ali ;
Colin, G. ;
Souweine, B. ;
Asehnoune, K. ;
Mercier, E. ;
Chimot, L. ;
Charpentier, C. ;
Francois, B. ;
Boulain, T. ;
Petitpas, F. ;
Constantin, J. -M. ;
Dhonneur, G. ;
Baudin, F. ;
Combes, A. ;
Bohe, J. ;
Loriferne, J. -F. ;
Amathieu, R. ;
Cook, F. ;
Slama, M. ;
Leroy, O. ;
Capellier, G. ;
Dargent, A. ;
Hissem, T. ;
Maxime, V. ;
Bellissant, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (09) :809-818
[6]
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[7]
Corticosteroids for treating sepsis [J].
Annane, Djillali ;
Bellissant, Eric ;
Bollaert, Pierre Edouard ;
Briegel, Josef ;
Keh, Didier ;
Kupfer, Yizhak .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (12)
[8]
Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults A Systematic Review [J].
Annane, Djillali ;
Bellissant, Eric ;
Bollaert, Pierre-Edouard ;
Briegel, Josef ;
Confalonieri, Marco ;
De Gaudio, Raffaele ;
Keh, Didier ;
Kupfer, Yizhak ;
Oppert, Michael ;
Meduri, G. Umberto .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (22) :2362-2375
[9]
Subsequent Infections in Survivors of Sepsis: Epidemiology and Outcomes [J].
不详 .
JOURNAL OF INTENSIVE CARE MEDICINE, 2014, 29 (02) :87-95
[10]
[Anonymous], 2008, INTENS CARE MED, DOI [DOI 10.1007/s00134-007-0934-2, DOI 10.1007/s00134-008-1040-9]